Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Quantum Corp
QMCO
$1.03B
| $2.35M | ﹤0.01% |
24,031
+3,668
| +18% | +$353K |
|
|
EVOL
2127
DELISTED
Evolving Systems, Inc.
EVOL
| $2.35M | ﹤0.01% |
408,499
+15,900
| +4% | +$85.1K |
|
|
TSC
2128
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.34M | ﹤0.01% |
185,500
+33,942
| +22% | +$416K |
|
2129
First Citizens BancShares
FCNCA
$25.9B
| $2.33M | ﹤0.01% |
9,300
+3,296
| +55% | +$792K |
|
2130
Insmed
INSM
$27B
| $2.33M | ﹤0.01% |
+183,787
| New | +$2.42M |
|
2131
Associated Banc-Corp
ASB
$6.11B
| $2.32M | ﹤0.01% |
129,379
+109,779
| +560% | +$1.92M |
|
2132
Movado Group
MOV
$803M
| $2.32M | ﹤0.01% |
+84,200
| New | +$2.25M |
|
|
PCOM
2133
DELISTED
Points.com Inc. Common Shares
PCOM
| $2.32M | ﹤0.01% |
265,900
+37,000
| +16% | +$282K |
|
|
CNCE
2134
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.31M | ﹤0.01% |
169,200
-19,689
| -10% | -$283K |
|
2135
LGI Homes
LGIH
$1.39B
| $2.3M | ﹤0.01% |
95,100
-249,200
| -72% | -$5.55M |
|
2136
Varonis Systems
VRNS
$5.17B
| $2.3M | ﹤0.01% |
+377,700
| New | +$2.22M |
|
2137
Addus HomeCare
ADUS
$2.17B
| $2.29M | ﹤0.01% |
133,500
-23,100
| -15% | -$478K |
|
|
INWK
2138
DELISTED
InnerWorkings, Inc.
INWK
| $2.29M | ﹤0.01% |
287,500
+207,700
| +260% | +$1.46M |
|
2139
Crown Crafts
CRWS
$30.7M
| $2.28M | ﹤0.01% |
246,509
+16,609
| +7% | +$142K |
|
|
GDEN
2140
DELISTED
Golden Entertainment
GDEN
| $2.28M | ﹤0.01% |
210,000
+52,800
| +34% | +$537K |
|
|
TMHC
2141
DELISTED
Taylor Morrison
TMHC
| $2.27M | ﹤0.01% |
+160,800
| New | +$2.13M |
|
2142
Advanced Micro Devices
AMD
$840B
| $2.26M | ﹤0.01% |
794,400
+754,900
| +1,911% | +$1.72M |
|
|
TRIB
2143
Trinity Biotech
TRIB
$7.88M
| $2.26M | ﹤0.01% |
1,294
-53
| -4% | -$84.4K |
|
2144
NeoGenomics
NEO
$2.05B
| $2.26M | ﹤0.01% |
334,700
-141,900
| -30% | -$934K |
|
|
ONE
2145
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
| $2.25M | ﹤0.01% |
576,131
+325,320
| +130% | +$1.21M |
|
|
CDK
2146
DELISTED
CDK Global, Inc.
CDK
| $2.25M | ﹤0.01% |
48,300
-69,400
| -59% | -$3.09M |
|
|
AFH
2147
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $2.25M | ﹤0.01% |
123,900
-7,200
| -5% | -$127K |
|
2148
HF Sinclair
DINO
$16.7B
| $2.25M | ﹤0.01% |
63,582
-1,321,800
| -95% | -$45.5M |
|
2149
Orrstown Financial Services
ORRF
$852M
| $2.25M | ﹤0.01% |
129,700
+6,200
| +5% | +$108K |
|
2150
Integra LifeSciences
IART
$1.43B
| $2.25M | ﹤0.01% |
66,660
-36,000
| -35% | -$1.12M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.